NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,647,871 | +347.2% | 365,728 | +534.9% | 0.01% | +500.0% |
| Q4 2022 | $592,128 | -84.3% | 57,600 | -72.1% | 0.00% | -83.3% |
| Q3 2022 | $3,762,000 | -69.6% | 206,700 | -14.2% | 0.01% | -50.0% |
| Q2 2022 | $12,388,000 | -67.9% | 240,881 | -54.0% | 0.01% | -40.0% |
| Q1 2022 | $38,572,000 | -73.5% | 523,723 | -48.4% | 0.02% | -84.7% |
| Q4 2021 | $145,307,000 | -3.4% | 1,015,633 | +39.9% | 0.13% | +14.9% |
| Q3 2021 | $150,491,000 | +383.9% | 725,920 | +395.5% | 0.11% | +322.2% |
| Q2 2021 | $31,101,000 | +54.7% | 146,492 | +32.1% | 0.03% | +50.0% |
| Q1 2021 | $20,109,000 | -33.5% | 110,912 | -59.1% | 0.02% | -18.2% |
| Q4 2020 | $30,221,000 | +437.5% | 271,017 | +422.3% | 0.02% | +450.0% |
| Q3 2020 | $5,622,000 | +7201.3% | 51,889 | +166.8% | 0.00% | – |
| Q4 2019 | $77,000 | -50.3% | 19,450 | -36.7% | 0.00% | – |
| Q3 2019 | $155,000 | +36.0% | 30,745 | +58.1% | 0.00% | – |
| Q2 2019 | $114,000 | – | 19,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |